Skip to content

The effect of infusion of propofol before it's induction dose on injection pain

Comparative study of the effect of propofol infusion before injection of induction dose on injection induced pain and changes in serum complement in patients candidate for general anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170301032837N2
Enrollment
60
Registered
2017-12-03
Start date
2017-02-13
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain caused by propofol injection. Adverse effect of intravenous anesthetics

Interventions

Intervention 1: Control group: After IV catheterizationin the patient's hand, 5 cc blood samples are taken to measure the serum level of complement factor C3. One minute later fentanyl 3 micg/kg and m
Prevention
Control group: After IV catheterizationin the patient's hand, 5 cc blood samples are taken to measure the serum level of complement factor C3. One minute later fentanyl 3 micg/kg and midazolam 0.15 mg
Intervention group 1: After intravenous catheterization, 5 cc blood samples are taken to measure the serum level of complement factor C3.Then propofol infusion 50µg/kg/min ( Manufactured by: Freseniu
Intervention group 2: After intravenous catheterization, 5 cc blood samples are taken to measure the serum level of complement factor C3.Then propofol infusion 100µg/kg/min ( Manufactured by: Freseniu

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients are candidates for general anesthesia ASA I & II

Exclusion criteria

Exclusion criteria: uncontrolled chronic and acute diseases age >60 age<18 history of hypersensitivity to drugs and foods History of using NSAIDS and corticostroides opioid addiction

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: At the time of the intervention. Method of measurement: visual analogue scale of pain.

Secondary

MeasureTime frame
Changes in serum level of complement factor C3. Timepoint: Immediately before the intervention and two minutes after the intervention. Method of measurement: Blood sampling and laboratory measurements.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehrooz Zaman

Iran University of Medical Sciences

zaman.b@iums.ac.ir+98 21 8871 7272

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026